Home › Funds › EcoR1 Capital, LLC › ANAB
EcoR1 Capital, LLC position in ANAB
ANAPTYSBIO INC COM · Health Care
EcoR1 Capital, LLC reported holding 7,880,094 shares of ANAB (ANAPTYSBIO INC COM) in its Q2 2026 13F filing — a position valued at US$531.9M, representing 27.30% of its reported portfolio and ranking #2 among its reported holdings. EcoR1 Capital, LLC has disclosed ANAB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's ANAB position evolved
EcoR1 Capital, LLC first disclosed a stake in ANAB in Q3 2023 at 7,521,024 shares (US$135.1M). The position peaked in Q2 2026 at 7,880,094 shares, worth US$531.9M. Across 12 filings, EcoR1 Capital, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 7,880,094 shares valued at US$531.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.52M | $135.08M | New |
| Q4 2023 | 7.52M | $161.10M | Hold |
| Q1 2024 | 7.52M | $169.37M | Hold |
| Q2 2024 | 7.52M | $188.48M | Hold |
| Q3 2024 | 7.79M | $261.13M | Add |
| Q4 2024 | 7.87M | $104.24M | Add |
| Q1 2025 | 7.88M | $146.49M | Hold |
| Q2 2025 | 7.88M | $174.94M | Hold |
| Q3 2025 | 7.88M | $241.29M | Hold |
| Q4 2025 | 7.88M | $382.03M | Hold |
| Q1 2026 | 7.88M | $437.03M | Hold |
| Q2 2026 | 7.88M | $531.91M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANAB and 13F data
ANAB (ANAPTYSBIO INC COM) is a Health Care company. 46 other funds we track also report a position in ANAB — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M), Sanofi (US$55.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANAB
- TANG CAPITAL MANAGEMENT LLC 1.33M sh · $89.83M · Q2 2026
- Affinity Asset Advisors, LLC 826.11K sh · $55.76M · Q2 2026
- Sanofi 821.92K sh · $55.48M · Q2 2026
- 683 Capital Management, LLC 660.00K sh · $44.55M · Q2 2026
- Palo Alto Investors LP 603.49K sh · $40.74M · Q2 2026
- First Light Asset Management, LLC 582.00K sh · $39.29M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 497.00K sh · $33.55M · Q2 2026
- Sofinnova Investments, Inc. 493.54K sh · $33.31M · Q2 2026
- Coppell Advisory Solutions LLC 3.64K sh · $16.58M · Q2 2026
- Greenhaven Road Investment Management, L.P. 171.06K sh · $11.55M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held ANAB?
EcoR1 Capital, LLC has disclosed ANAB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EcoR1 Capital, LLC's current position in ANAB?
As of Q2 2026, EcoR1 Capital, LLC holds 7.88M shares of ANAB (ANAPTYSBIO INC COM), valued at $531.91M, representing 27.30% of its reported portfolio and ranking #2.
Has EcoR1 Capital, LLC been buying or selling ANAB?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in ANAB. The position peaked in Q2 2026 at 7.88M shares.
Which other funds hold ANAB?
Other major institutional holders of ANAB include TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, Sanofi, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.